Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem.
作者信息
Dyer Janet
出版信息
P T. 2019 Jan;44(1):12-14.
Abstract
摘要
相似文献
1
Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem.新生儿呼吸窘迫综合征：应对全球性问题
P T. 2019 Jan;44(1):12-14.
2
Scenario of Neonatal Respiratory Distress in Tertiary Hospital.三级医院新生儿呼吸窘迫情况
J Nepal Health Res Counc. 2018 Jul 3;16(2):131-135.
3
A novel approach to study oxidative stress in neonatal respiratory distress syndrome.一种研究新生儿呼吸窘迫综合征氧化应激的新方法。
BBA Clin. 2014 Dec 8;3:65-9. doi: 10.1016/j.bbacli.2014.12.001. eCollection 2015 Jun.
4
[Do antenatal corticosteroids in term elective cesarean sections reduce neonatal respiratory morbidity?].[足月择期剖宫产术中使用产前糖皮质激素能否降低新生儿呼吸系统发病率？]
Medwave. 2015 Oct 7;15(9):e6280. doi: 10.5867/medwave.2015.09.6280.
5
Umbilical cord blood and neonatal endothelin-1 levels in preterm newborns with and without respiratory distress syndrome.患有和未患呼吸窘迫综合征的早产儿的脐带血及新生儿内皮素-1水平
Braz J Med Biol Res. 2005 Sep;38(9):1417-22. doi: 10.1590/s0100-879x2005000900017. Epub 2005 Aug 26.
6
Postnatal thyroid hormones for respiratory distress syndrome in preterm infants.产后甲状腺激素用于早产儿呼吸窘迫综合征
Cochrane Database Syst Rev. 2007 Jan 24(1):CD005946. doi: 10.1002/14651858.CD005946.pub2.
7
Primary ciliary dyskinesia and neonatal respiratory distress.原发性纤毛运动障碍与新生儿呼吸窘迫
Pediatrics. 2014 Dec;134(6):1160-6. doi: 10.1542/peds.2014-0808.
8
Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.外源性表面活性剂治疗新生儿呼吸窘迫综合征及其在成人呼吸窘迫综合征中的潜在作用。
Drugs. 1989 Oct;38(4):591-611. doi: 10.2165/00003495-198938040-00006.
9
Respiratory distress in neonates with special reference to pneumonia.新生儿呼吸窘迫，特别提及肺炎
Indian Pediatr. 2002 Jun;39(6):529-37.
10
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.棕榈酸考福斯昔尔。合成表面活性剂制剂（固尔苏）治疗新生儿呼吸窘迫综合征的疗效及临床耐受性综述。
Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009.
引用本文的文献
1
Comparative Efficacy and Safety Profile of the Combination of Pulmonary Surfactant and Budesonide vs. Surfactant Alone in the Management of Neonatal Respiratory Distress Syndrome: An Updated Meta-Analysis.肺表面活性物质与布地奈德联合应用与单独使用肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效和安全性比较：一项更新的荟萃分析
Medicina (Kaunas). 2025 Jul 23;61(8):1329. doi: 10.3390/medicina61081329.
2
Storage and in-use stability of an excipient enhanced growth (EEG) synthetic lung surfactant powder formulation.一种辅料增强生长（EEG）型合成肺表面活性剂粉末制剂的储存稳定性及使用稳定性
Drug Dev Ind Pharm. 2025 Jul;51(7):747-757. doi: 10.1080/03639045.2025.2508845. Epub 2025 May 26.
3
A short-course of low-dose insulin detemir effectively decreases blood glucose levels in gestational diabetic women undergoing dexamethasone treatment to promote newborn lung maturity.短期小剂量地特胰岛素可有效降低接受地塞米松治疗以促进新生儿肺成熟的妊娠期糖尿病妇女的血糖水平。
Medicine (Baltimore). 2025 Jan 17;104(3):e40547. doi: 10.1097/MD.0000000000040547.
4
c.838C>T (p.Arg280Cys, R280C) and c.697C>T (p.Gln233Ter, Q233X, Q233*) as Causative Variants for RDS: A Family Case Study and Literature Review.c.838C>T（p.Arg280Cys，R280C）和c.697C>T（p.Gln233Ter，Q233X，Q233*）作为呼吸窘迫综合征的致病变异：一项家系病例研究及文献综述
Biomedicines. 2024 Oct 18;12(10):2390. doi: 10.3390/biomedicines12102390.
5
Clinical cause of neonatal mortality in Iran: analysis of the national Iranian Maternal And Neonatal network.伊朗新生儿死亡的临床病因：伊朗母婴网络的国家分析。
BMJ Paediatr Open. 2024 Mar 20;8(1):e002315. doi: 10.1136/bmjpo-2023-002315.
6
Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies.新生儿呼吸窘迫综合征的描述性和功能基因组学：从肺发育到靶向治疗。
Int J Mol Sci. 2024 Jan 4;25(1):649. doi: 10.3390/ijms25010649.
7
Non-invasive ventilation in neonates: a review of current literature.新生儿无创通气：当前文献综述
Front Pediatr. 2023 Nov 28;11:1248836. doi: 10.3389/fped.2023.1248836. eCollection 2023.
8
Prevalence and Missed Cases of Respiratory Distress Syndrome Disease Amongst Neonatal Deaths Enrolled in the Kenya Child Health and Mortality Prevention Surveillance Network (CHAMPS) Program Between 2017 and 2021.2017年至2021年期间，肯尼亚儿童健康与死亡率预防监测网络（CHAMPS）项目登记的新生儿死亡中呼吸窘迫综合征疾病的患病率及漏报病例
Glob Pediatr Health. 2023 Dec 5;10:2333794X231212819. doi: 10.1177/2333794X231212819. eCollection 2023.
9
Incidence and predictors of respiratory distress syndrome among low birth weight neonates in the first seven days in Northwest Ethiopia Comprehensive Specialized Hospitals, 2023: A retrospective follow-up study.2023 年，在埃塞俄比亚西北部综合专科医院，对出生体重低的新生儿在头 7 天内发生呼吸窘迫综合征的发生率及其预测因素进行回顾性随访研究。
BMJ Open. 2023 Nov 19;13(11):e079063. doi: 10.1136/bmjopen-2023-079063.
10
Feasibility of a novel ultra-low-cost bubble CPAP (bCPAP) System for neonatal respiratory support at Muhimbili National Hospital, Tanzania.坦桑尼亚姆万扎国立医院新型超低成本气泡持续气道正压通气（bCPAP）系统用于新生儿呼吸支持的可行性。
PLoS One. 2022 Dec 30;17(12):e0269147. doi: 10.1371/journal.pone.0269147. eCollection 2022.
本文引用的文献
1
Updates on the Status of Vitamin D as a Risk Factor for Respiratory Distress Syndrome.维生素D作为呼吸窘迫综合征风险因素的现状更新
Adv Pharmacol Sci. 2018 Sep 30;2018:8494816. doi: 10.1155/2018/8494816. eCollection 2018.
2
Less is More: Modern Neonatology.少即是多：现代新生儿学
Rambam Maimonides Med J. 2018 Jul 30;9(3):e0023. doi: 10.5041/RMMJ.10344.
3
Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.雾化表面活性剂以减轻呼吸窘迫严重程度的研究：一项双盲、平行、随机对照试验。
Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F313-F319. doi: 10.1136/archdischild-2018-315051. Epub 2018 Jul 26.
4
Preterm Neonates with Respiratory Distress Syndrome: Ventilator-Induced Lung Injury and Oxidative Stress.早产儿呼吸窘迫综合征：呼吸机所致肺损伤与氧化应激。
J Immunol Res. 2018 Apr 23;2018:6963754. doi: 10.1155/2018/6963754. eCollection 2018.
5
Treatment Patterns and Clinical Outcomes in Neonates Diagnosed With Respiratory Distress Syndrome in a Low-Income Country: A Report From Bangladesh.在低收入国家中，诊断为呼吸窘迫综合征的新生儿的治疗模式和临床结局：来自孟加拉国的报告。
Anesth Analg. 2018 May;126(5):1684-1686. doi: 10.1213/ANE.0000000000002865.
6
Inhaled Nitric Oxide in Extremely Premature Neonates With Respiratory Distress Syndrome.吸入一氧化氮治疗呼吸窘迫综合征的极早产儿。
Pediatrics. 2018 Mar;141(3). doi: 10.1542/peds.2017-3108. Epub 2018 Feb 9.
7
Effect of pulmonary surfactant combined with mechanical ventilation on oxygenation functions and expressions of serum transforming growth factor-beta1 (TGF-β1) and bone morphogenetic protein 7 (BMP-7) of neonatal respiratory distress syndrome.肺表面活性物质联合机械通气对新生儿呼吸窘迫综合征氧合功能及血清转化生长因子-β1（TGF-β1）和骨形态发生蛋白 7（BMP-7）表达的影响。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4357-4361.
8
Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort.早产儿呼吸窘迫综合征与丹麦队列中癫痫的风险。
Eur J Epidemiol. 2018 Mar;33(3):313-321. doi: 10.1007/s10654-017-0308-1. Epub 2017 Sep 8.
9
Ventilation in Extremely Preterm Infants and Respiratory Function at 8 Years.极早产儿的通气与 8 岁时的呼吸功能。
N Engl J Med. 2017 Jul 27;377(4):329-337. doi: 10.1056/NEJMoa1700827.
10
Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.用于呼吸窘迫综合征的表面活性剂：一种具有创新应用的常见药物的新思路。
Neonatology. 2017;111(4):408-414. doi: 10.1159/000458466. Epub 2017 May 25.
Zotero 插件